Picture of Arvinas logo

ARVN — Arvinas News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Arvinas Inc expected to post a loss of 100 cents a share - Earnings Preview

Arvinas Inc ARVN.OQ ARVN.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 for the period ending June 30 2025

The New Haven Connecticut-based  company is expected to report a 60.3% decrease in revenue to $30.374 million from $76.5 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Arvinas Inc is for a loss of 100 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Arvinas Inc is $14.00, about 47% above its last closing price of $7.42

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDINGSTARMINESMARTESTIMATE¬ģLSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-1.00-0.951.14Beat220.4
Dec. 31 2025-1.07-1.02-0.63Beat38.3
Sep. 30 2024-0.96-0.96-0.68Beat29.3‚Äč
Jun. 30 2024-0.82-0.86-0.49Beat43.2
‚Äč‚ÄčMar. 31 2024-1.42-1.42-0.97Beat31.6
Dec. 31 2023-1.20-1.27-2.53Missed-99.6‚Äč
Sep. 30 2023-1.60-1.58-1.18Beat25.1
Jun. 30 2023-1.64-1.65-1.25Beat24.2
This summary was machine generated August 4 at 12:53 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Arvinas

See all news